Study Finds Prozac No More Effective Than Placebo for Treating Childhood Depression
By
pseudolus
Toasted golden, schmeared with insight. Top of the rack.
Summary
Research shows Prozac has no clinical benefit over placebo for treating depression in children and adolescents, leading experts to recommend clinical guidelines should no longer recommend the antidepressant for young people. The study found Prozac was no more effective than placebo and exposed children to potential side effects without benefit. This comes amid high rates of mental health conditions in youth globally, with UK guidelines currently allowing Prozac for moderate to severe depression in under-18s.
Key quotes
· 4 pulledClinical guidelines should no longer recommend Prozac for children, according to experts, after research showed it had no clinical benefit for treating depression in children and adolescents.
Globally one in seven 10- to 19-year-olds have a mental health condition, according to the World Health Organization.
In the UK, about a quarter of older teenagers and up to a fifth of younger children have anxiety, depression or other mental health problems.
Clinical guidelines should change to avoid exposing young people to potentially harmful side-effects, researchers say.
You might also wanna read
Major Lancet Review Finds Medicinal Cannabis Ineffective for Anxiety, Depression, and PTSD
A major systematic review published in The Lancet finds that medicinal cannabis does not effectively treat anxiety, depression, or PTSD, des
Exercise Shows Comparable Effectiveness to Therapy for Depression Treatment
A comprehensive review of scientific studies finds that exercise can be as effective as psychological therapy for treating depression, with
Research Review Finds Association Between Cat Ownership and Increased Schizophrenia Risk
A comprehensive analysis of 17 studies spanning 44 years across 11 countries found a significant association between cat ownership and incre
sciencealert.com·6mo ago
Researchers develop phage-based preventive treatment for newborn meningitis caused by E. coli K1
Researchers from the Biozentrum, University of Basel, and ETH Zurich have developed a novel preventive treatment for newborn meningitis caus
biozentrum.unibas.ch·2h ago
Exploring the science behind quantum effects in healthcare: separating research from pseudoscience
The article explores the intersection of quantum physics and healthcare, distinguishing between pseudoscientific "quantum therapies" and leg
newscientist.com·7h ago
Experimental pill daraxonrasib nearly doubles survival time in advanced pancreatic cancer trial
A novel experimental pill called daraxonrasib has shown promise in extending survival for patients with advanced pancreatic cancer. The drug
chicagotribune.com·7h ago